Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J Clin Invest. 2000 Jul; 106(1):117-24.
View in:
PubMed
subject areas
Animals
Antigens, CD34
CD56 Antigen
Humans
Interleukin-2
Killer Cells, Natural
Lymphocyte Activation
Rabbits
Recombinant Proteins
authors with profiles
Wendy Stock